Fund Holdings — Avoro Capital Advisors LLC

Total Portfolio Value:
$9.69B
Total Bought:
$245.39M
Total Sold:
$1.22B
Net Transaction:
-$974.86M
Notable People:
Behzad Aghazadeh, Avoro Capital L.P.
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
United Therapeutics Corporation(UTHR)2,777,7772,755,555-22,222$1.51B$1.49B15.41%-$11.88M
Ascendis Pharma A/S(ASND)5,111,1115,050,000-61,111$1.36B$1.15B11.87%-$212.69M
Krystal Biotech, Inc.(KRYS)2,888,8882,888,8880$1.07B$960.73M9.91%-$112.98M
argenx SEADR(ARGX)1,000,0001,000,0000$927.77M$958.91M9.89%+$31.14M
Madrigal Pharmaceuticals, Inc.(MDGL)1,833,3331,833,3330$984.41M$923.93M9.53%-$60.48M
Kymera Therapeutics, Inc.(KYMR)7,474,7477,474,7470$857.13M$835.60M8.62%-$21.53M
Arrowhead Pharmaceuticals, Inc.(ARWR)11,355,55511,000,000-355,555$925.59M$719.95M7.43%-$205.64M
Revolution Medicines, Inc.(RVMD)2,297,0002,145,000-152,000$430.18M$440.28M4.54%+$10.10M
Cytokinetics, Incorporated(CYTK)4,999,9994,900,000-99,999$425.95M$322.96M3.33%-$102.99M
Definium Therapeutics, Inc.(DFTX)7,188,8887,050,000-138,888$338.17M$268.32M2.77%-$69.84M
Structure Therapeutics IncADS6,555,5556,555,5550$351.84M$204.99M2.12%-$146.84M
Xenon Pharmaceuticals Inc.(XENE)5,777,7775,500,000-277,777$348.75M$204.54M2.11%-$144.20M
Vera Therapeutics, Inc.(VERA)5,723,8885,635,000-88,888$245.61M$181.95M1.88%-$63.66M
uniQure N.V.(QURE)6,727,7776,727,7770$309.88M$162.54M1.68%-$147.34M
Celcuity Inc.(CELC)3,400,0001,500,000-1,900,000$355.71M$119.28M1.23%-$236.43M
Taysha Gene Therapies, Inc.(TSHA)23,888,88823,888,8880$162.68M$116.34M1.20%-$46.34M
Ocular Therapeutix, Inc.(OCUL)12,540,00012,380,300-159,700$123.14M$94.96M0.98%-$28.19M
Damora Therapeutics Inc03,783,000+3,783,000$0$80.50M0.83%+$80.50M
Hemab Therapeutics Hldgs Inc1,925,1501,892,372-32,778$70.71M$58.36M0.60%-$12.35M
Viridian Therapeutics, Inc.(VRDN)2,500,0002,500,0000$45.92M$51.48M0.53%+$5.55M
Septerna, Inc.(SEPN)1,337,5001,300,000-37,500$44.79M$50.87M0.52%+$6.08M
ABIVAX Société AnonymeADS(ABVX)0488,000+488,000$0$48.32M0.50%+$48.32M
Scribe Therapeutics Inc02,598,973+2,598,973$0$47.83M0.49%+$47.83M
Faeth Therapeutics, Inc.(FTH)1,444,0391,410,000-34,039$36.10M$41.93M0.43%+$5.83M
GH Research PLC(GHRS)1,800,0001,770,000-30,000$48.38M$41.56M0.43%-$6.82M
Biohaven Ltd02,750,000+2,750,000$0$36.71M0.38%+$36.71M
Avalo Therapeutics, Inc.(AVTX)2,333,3332,377,777+44,444$43.12M$36.45M0.38%-$6.67M
Braveheart Bio Inc01,255,000+1,255,000$0$25.35M0.26%+$25.35M
Whitehawk Therapeutics, Inc.(WHWK)2,849,4022,849,4020$13.05M$10.71M0.11%-$2.34M
Lexeo Therapeutics, Inc.(LXEO)1,489,189525,000-964,189$6.93M$1.77M0.02%-$5.16M
Damora Therapeutics, Inc.(DMRA)3,783,0000-3,783,000$98.40M$0—-$98.40M
Page 1 of 1
Avoro Capital Advisors LLC — 13F Holdings — Q3 2026 | TickerTrail